Facilitating cholangiocarcinoma inhibition by targeting CD47
Open Access
- 27 September 2024
- journal article
- research article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 140, 104935
Abstract
No abstract availableKeywords
Funding Information
- Khon Kaen University
This publication has 52 references indexed in Scilit:
- Diminishing acetyl-CoA carboxylase 1 attenuates CCA migration via AMPK-NF-κB-snail axisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023
- CD47 promotes cell growth and motility in epithelial ovarian cancerBiomedicine & Pharmacotherapy, 2019
- Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal CancerArchivum Immunologiae et Therapiae Experimentalis, 2017
- Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinomaTumor Biology, 2016
- CD47 is an adverse prognostic factor and a therapeutic target in gastric cancerCancer Medicine, 2015
- Potential targeted therapy for liver fluke associated cholangiocarcinomaJournal of Hepato-Biliary-Pancreatic Sciences, 2014
- New insights into the molecular pathogenesis of intrahepatic cholangiocarcinomaJournal of Gastroenterology, 2013
- Myeloperoxidase and elastase are only expressed by neutrophils in normal and in inflammed liverHistochemistry and Cell Biology, 2011
- Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreasHepatology, 2006
- Immunohistochemical phenotyping of liver macrophages in normal and diseased human liverHepatology, 1994